Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 1 , Pages 60-63 , January 2012

Primary vs. post-chemotherapy retroperitoneal lymph node dissection (RPLND) in patients with presence of teratoma at orchiectomy

Received 2 October 2009 ,Revised 7 December 2009 ,Accepted 7 December 2009.

References 

  1. Williams SB , McDermott DW , Winston D , et al.  Retroperitoneal lymph node dissection in patients with high risk testicular cancer . J Urol . 2009;181:2097–2102
  2. Stephenson AJ , Bosl GJ , Motzer RJ , et al.  Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer . J Clin Oncol . 2007;25:5597–5602
  3. Beck S , Peterson MD , Bihrle R , et al.  Short term morbidity of primary retroperitoneal lymph node dissection in a contemporary group of patients . J Urol . 2007;178:504–506
  4. Brenner DJ , Hall EJ . Computed tomography—an increasing source of radiation exposure . NEJM . 2007;357:2277–2284
  5. Tarin TV , Sonn G , Shinghal R . Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography . J Urol . 2009;181:627–632
  6. Richardi L , Scelo G , Boffetta P , et al.  Second malignancies among survivors of germ-cell testicular cancer: A pooled analysis between 13 cancer registries . Int J Cancer . 2006;120:623–631
  7. Howard R , Gilbert E , Lynch CF , et al.  Risk of leukemia among survivors of testicular cancer: A population-based study of 42,722 Patients . AEP . 2008;18:416–421
  8. van den Belt-Dusebout AW , de Wit R , Gietema JA , et al.  Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer . J Clin Oncol . 2007;25:4370–4378
  9. Haugnes HS , Aass N , Fossa SD , et al.  Pulmonary function in long-term survivors of testicular cancer . J Clin Oncol . 2009;27:2779–2786
  10. NCCN Clinical Practice Guidelines in Oncology . 2010; V. 1 www.nccn.org
  11. Motzer RJ , Amsterdam A , Prieto V , et al.  Teratoma with malignant transformation: Diverse malignant histologies arising in men with germ cell tumors . J Urol . 1998;159:133–138
  12. Little JS , Foster RS , Ulbright TM , et al.  Unusual neoplasms detected in testis cancer patients undergoing post-chemotherapy retroperitoneal lymphadenectomy . J Urol . 1994;152:1144–1149
  13. Comiter CV , Kibel AS , Richie JP , et al.  Prognostic features of teratomas with malignant transformation: A clinicopathological study of 21 cases . J Urol . 1998;159:859
  14. Lutke Holzik MF , Hoekstra HJ , Mulder NH , et al.  Non-germ cell malignancy in residual or recurrent mass after chemotherapy for nonseminomatous testicular germ cell tumor . Ann Surg Oncol . 2003;10:131–135
  15. Inci K , Dogan HS , Akdogan B , et al.  Presence of teratoma in orchiectomy specimen increases the need for post-chemotherapy RPLND . Urol Oncol . 2009; in press
  16. Richie JP . Clinical stage 1 testicular cancer: The role of modified retroperitoneal lymphadenectomy . J Urol . 1990;144:1160–1163
  17. Donohue JP , Foster RS , Rowland RG , et al.  Nerve-sparing retroperitoneal lymphadenectomy with preservation of ejaculation . J Urol . 1990;144(2 Pt 1):287–291
  18. Donohue JP , Foster RS . Retroperitoneal lymphadenectomy in staging and treatment (The development of nerve-sparing techniques) . Urol Clin North Am . 1998;25:461–468
  19. Leibovitch I , Foster RS , Ulbright TM , et al.  Adult primary pure teratoma of the testis (The Indiana experience) . Cancer . 1995;75:2244–2250
  20. Beck SD , Foster RS , Bihrle R , et al.  Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in post-chemotherapy nonseminomatous testis cancer . J Urol . 2002;168:1402–1404
  21. Einhorn LH . Testicular cancer as a model for a curable neoplasm: The Richard and Hinda Rosenthal Foundation Award Lecture . Cancer Res . 1981;41:3275–3280

 No reprints will be available.

PII: S1078-1439(09)00406-2

doi: 10.1016/j.urolonc.2009.12.006

Urologic Oncology: Seminars and Original Investigations
Volume 30, Issue 1 , Pages 60-63 , January 2012

Article Tools